Clindamycin Dosing for Skin and Soft Tissue Infections

Adult Dosing by Severity

The recommended dose for uncomplicated purulent cellulitis and simple skin and soft tissue infections (SSTIs) is 300-450 mg orally every 6-8 hours 1, 2
For severe or complicated infections, the recommended dose is 600 mg intravenously every 8 hours 1, 3, 4
Treatment duration for uncomplicated infections should be 5-10 days based on clinical response, with 7 days being typical 1, 3
For life-threatening infections, doses up to 900 mg IV every 8 hours may be considered 1, 4

Clindamycin is an excellent single-agent choice for empirical therapy of purulent cellulitis because it covers both CA-MRSA and β-hemolytic streptococci 1, 3
Clindamycin should only be used when local MRSA clindamycin resistance rates are <10% 3, 4
Be aware of inducible clindamycin resistance in erythromycin-resistant MRSA strains 3, 4

Uncomplicated SSTIs should be treated for 5-7 days if clinical improvement is evident 1, 3
Complicated SSTIs should be treated for 10-14 days depending on response 1, 4
Clinical improvement should be evident within 48-72 hours; if not, consider inadequate source control or deeper infection 4

Incision and drainage is the cornerstone of abscess treatment and may be sufficient alone for simple abscesses 4
For abscesses with minimal surrounding cellulitis, drainage alone achieves 85-90% cure rates 4

For complicated or severe infections, the Infectious Diseases Society of America recommends 450 mg of clindamycin every 6 hours or 600 mg every 8 hours 5
The IDSA guidelines emphasize that purulent infections require the higher 300-450 mg dosing to achieve adequate tissue concentrations and prevent treatment failure, with a typical dosing regimen of 450 mg every 6 hours or 600 mg every 8 hours for complicated or severe infections 5

The IDSA guidelines recommend against underdosing at 150 mg every 6 hours for a purulent infection, reserving this dose only for minor, non-purulent infections, and instead recommend 300-450 mg dosing for purulent infections 5